The genomic landscape associated with resistance to aromatase inhibitors in breast cancer

Aromatase inhibitors (AI) are drugs that are widely used in treating estrogen receptor (ER)–positive breast cancer patients. Drug resistance is a major obstacle to aromatase inhibition therapy. There are diverse reasons behind acquired AI resistance. This study aims at identifying the plausible caus...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadasivam, Kirithika, Manoharan, Jeevitha Priya, Palanisamy, Hema, Vidyalakshmi, Subramanian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korea Genome Organization 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326531/
https://www.ncbi.nlm.nih.gov/pubmed/37415453
http://dx.doi.org/10.5808/gi.23012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326531/
https://www.ncbi.nlm.nih.gov/pubmed/37415453
http://dx.doi.org/10.5808/gi.23012

Ejemplares similares